Profectus BioSciences Inc. Names Shawn Patrick O... (mmation business unit. Asthe area leader...)

Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO

Date:1/28/2008

mmation business unit. As the area leader, O'Brien was responsible for research and development, marketing and sales of the products in the area. From 1987 through 2001, he held various management positions at AstraZeneca in global and domestic roles in the USA, Canada, and the UK. Earlier, he was with the Upjohn Company of Canada.

O'Brien succeeds Joseph F. Berardino, who established a solid foundation for the company in its early years by putting the business platform in place to secure funding for the Company. Joe also played a critical role in solidifying partnerships to progress the five technology platforms. The board of directors credits Berardino for the company's emergence as a successful biotechnology business. Berardino will continue with the company as a director.

"I have enjoyed working with the founding scientists, management, board and staff of the company to bring Profectus to where it is today. The opportunities before us are immense and the company is on solid footing to make the most of our science and technology. Shawn is the ideal leader to take the helm as CEO," said Berardino.

In addition, the company's board of directors announced that Donald R. Caldwell will serve as its chairman. Caldwell, who initially joined the Profectus board of directors in June 2007, is founder, chairman and chief executive officer of Cross Atlantic Capital Partners Inc., an international venture capital firm focused on highly innovative technology companies.

Prior to founding Cross Atlantic Capital Partners, Caldwell was president and chief operating officer of Safeguard Scientifics and served in a number of executive and financial positions, including chief administrative officer of a predecessor company of Cambridge Technology Partners, Inc. and president of Atlantic Financial. Earlier, Caldwell earned his CPA and was a partner in the national office of Arthur Young & Co., after receiving his masters of business administration from the G
'/>"/>

SOURCE Profectus BioSciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer

Post Your Comments:

(Date:3/16/2010)... Stock Exchange Symbol: MS , ... , , ... ... EDMONTON , March 16 ... ...

(Date:3/16/2010)... PharmAthene, Inc. (Amex: PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results ... ... , ... ... ...

(Date:3/16/2010)... March 16 The Gynecologic Cancer Foundation (GCF) and the Claudia ... as the first recipient of the $50,000 GCF/Claudia Cohen Prize for Outstanding ... (SGO) 41st Annual Meeting on Women,s Cancer, meeting in San Francisco ... ... ...

(Date:3/16/2010)... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice ... New Drug Application ("ANDA") for a generic version of Shire,s 1,mg, 2mg, ... ... ... , ...

[0] BioMS Medical Announces 2009 Year End Results [0] PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010 [0] Paul Goodfellow, PhD, Awarded First GCF/Claudia Cohen Prize for Outstanding Gynecologic Cancer Researcher [0] Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

... 18 Ranier Technology, a,Cambridge UK based spinal ... million) investment from new and existing investors to ... products.,The investment was made by Alliance Trust Equity ... testing and European launch of CAdisc L, the,lumbar ...

... do it. Even some bacteria and moss do it, ... to turn sunlight into useful fuel. Now, Penn State ... and produce recoverable hydrogen., "This is a proof-of-concept system ... 10 to 15 percent solar conversion efficiency might be ...

... and Second Sight Medical Products Inc, leading developers of ... completed enrollment of the first phase of a U.S .FDA ... They also announced that enrollment at key European sites is ... pleased that Second Sight, along with our fantastic clinical partners, ...

Other Biology Technology:Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 2 Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs 3 Solar cell directly splits water for hydrogen 2 Solar cell directly splits water for hydrogen 3 USC and second sight announce European clinical trial for Argus II retinal implant 2 USC and second sight announce European clinical trial for Argus II retinal implant 3

Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs Solar cell directly splits water for hydrogen USC and second sight announce European clinical trial for Argus II retinal implant

(Date:3/18/2010)... can live for twenty years, fertilizing millions of eggs ... activity. , Danish researchers who have studied ants ... 1992 discovered that in both ant and bee species ... fluid favors the survival of its own sperm over ... stored, leafcutter ant queens neutralize male-male sperm competition with ...

(Date:3/18/2010)... available in Spanish . , Feeding ... as part of their regular diet makes them ... a study by Agricultural Research Service (ARS) scientists ... and overall behavioral activity among young female pigs ... acquired through diet, is the precursor for the ...

(Date:3/18/2010)... Biotech, Inc., ( www.genwaybio.com ) the US-based diagnostic company ... is expanding this cancer testing program internationally. An ... YouTM Cancer Assessment in Greece starting in April. ... as well. GenWay currently offers this test in ... Sergey Sikora, Vice President of Business Development, said, "The ...

Breaking Biology News(10 mins):Females shut down male-male sperm competition in leafcutter ants 2 Tryptophan-enriched diet reduces pig aggression 2 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 1 Moravia Worldwide Names George Krawczyk as Sales Director for Ireland and UK 61905 2 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 1 Barbara Fentress Designer of the Denver International Airport and Convention Center Offers Her Private Mansion at Absolute Auction 61902 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 1 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 2 Ophthalmic Equipment Distributor Latham 26amp 3B Phillips SE Division Unveils Website 61899 3

[0] Females shut down male-male sperm competition in leafcutter ants [0] Tryptophan-enriched diet reduces pig aggression [0] GenWay Biotech extends the You Test You program overseas

... loss that direct the body to repair damaged tissue ... That,s not hard to do thanks to Canadian researchers, ... substance that attracts and supports cells necessary for tissue ... This development, published online in The FASEB Journal ...

... American Chemical Society (ACS) News Service Weekly PressPac with news ... News .,Please credit the individual journal or the American Chemical ... #1 FOR IMMEDIATE RELEASE , Clothing to crow about: ... the future, you may snuggle up in warm, cozy sweats ...

... technologies that make it easier to sequence the human ... Center have identified a series of genes that become ... These recurrent gene fusions are thought to be the ... The gene fusions discovered could potentially serve as a ...

'Smart scaffolds' may help heal broken hearts American Chemical Society's Weekly PressPac -- Jan. 7, 2009 U-M researchers discover new genes that fuse in cancer

96 Well Plate EB, RE bottom; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes. Guaranteed coefficient of variation (CVs)....

... Forma Tabletop orbital shakers combine high ... use. The patented triple-counterbalanced heavy-duty mechanism prevents ... with heavy, out-of-balance loads. Every other part, ... feet, to the thick machined aluminum platform ...

...

The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....

Biology Products:

96 Well Plate EB from Thermo Scientific Tabletop Orbital Shaker, 90-126V, 50/60 Hz or 180-253V, 50/60 Hz from Thermo Scientific Peptides from Thermo Scientific Horizontal Basis 1.2 (230V / 50Hz) from Thermo Scientific

Profectus BioSciences Inc. Names Shawn Patrick O...(mmation business unit. Asthe area leader...)